Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
63°
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Archives
Best of 2024
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Amgen
(NQ:
AMGN
)
313.71
+1.07 (+0.34%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Mar 14, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Amgen
< Previous
1
2
3
4
5
6
7
8
9
...
46
47
Next >
Motley Fool Market Cap Showdown: Bill Barker vs. Emily Flippen
Today 12:44 EDT
Via
The Motley Fool
Amgen's Uplizna Shows Improved Symptoms In Patients With Muscle Weakness Disorder Over One Year
March 13, 2025
Amgen's Uplizna met key endpoints in a Phase 3 gMG trial, showing sustained efficacy and improvement in muscle function with two doses a year.
Via
Benzinga
Amgen's Options: A Look at What the Big Money is Thinking
March 12, 2025
Via
Benzinga
Is Eli Lilly Stock a Buy?
March 11, 2025
Via
The Motley Fool
Amgen And Kyowa Kirin's Rocatinlimab Reduces Eczema Severity In Phase 3 Study
March 10, 2025
Amgen and Kyowa Kirin's rocatinlimab showed strong efficacy in Phase 3 trials for atopic dermatitis, achieving key endpoints in IGNITE and SHUTTLE studies.
Via
Benzinga
Assessing Amgen: Insights From 9 Financial Analysts
March 05, 2025
Via
Benzinga
Behind the Scenes of Amgen's Latest Options Trends
March 04, 2025
Via
Benzinga
3 Magnificent Growth Stocks to Buy in March
March 08, 2025
Via
The Motley Fool
2 Dividend Stocks to Buy for a Lifetime of Passive Income
March 07, 2025
Via
The Motley Fool
2 Reasons to Watch AMGN and 1 to Stay Cautious
March 06, 2025
Since September 2024, Amgen has been in a holding pattern, posting a small loss of 1.8% while floating around $314.91. The stock also fell short of the S&P 500’s 7% gain during that period.
Via
StockStory
Topics
Stocks
Exposures
US Equities
Amgen Challenges Novo Nordisk's Ozempic And Eli Lilly's Zepbound As Its Monthly Weight Loss Drug MariTide Enters Two Late-Stage Trials
March 06, 2025
Via
Benzinga
Amgen-AstraZeneca Partnered Asthma Drug Shows Rapid And Sustained Effect In Chronic Rhinosinusitis
March 03, 2025
Amgen and AstraZeneca's Tezspire showed significant reductions in nasal polyp severity, congestion, and surgery need in CRSwNP patients in the Phase 3 WAYPOINT trial.
Via
Benzinga
Looking Into Amgen's Recent Short Interest
February 19, 2025
Via
Benzinga
Amgen Unusual Options Activity For February 12
February 12, 2025
Via
Benzinga
Bitcoin, Magnificent 7 Lose Safe-Haven Status In 2025 As China ETFs, Dow Stocks Outperform
February 28, 2025
Many of the top-performing stocks and assets in recent years have stumbled at the start of 2025, with Bitcoin (CRYPTO: BTC) dropping to a three-month low.
Via
Benzinga
Topics
ETFs
Stocks
Exposures
US Equities
This Could Be the Best GLP-1 Stock to Buy in 2025
February 28, 2025
Via
The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
February 26, 2025
Via
Benzinga
These 3 Dow Jones Stocks Are Crushing It in 2025. Are They Still Buys?
February 25, 2025
Via
The Motley Fool
Topics
Stocks
Exposures
US Equities
Synchronicity: Denying The Unexplainable
February 24, 2025
Elon Musk and Neurolinks has been loud about the singularity—AI surpassing human intelligence. But has curiosity has lost its oomph?
Via
Talk Markets
Topics
Stocks / Equities
Large Cap Biopharmaceutical Metrics And Performance Q1 2025
February 20, 2025
Tariffs could have big impact on earnings in 2025.
Via
Talk Markets
Topics
Stocks / Equities
10 Health Care Stocks With Whale Alerts In Today's Session
February 11, 2025
Via
Benzinga
Gilead Sciences (GILD) Q4 Earnings: What To Expect
February 10, 2025
Biopharmaceutical company Gilead Sciences (NASDAQ:GILD) will be announcing earnings results tomorrow afternoon. Here’s what to expect.
Via
StockStory
Investing $1,000 in These 3 Beaten-Down Stocks Could Be a Brilliant Move
February 10, 2025
Via
The Motley Fool
3 Fabulous Dividend Stocks to Buy in February
February 09, 2025
Via
The Motley Fool
Vertex Pharmaceuticals (VRTX) Q4 Earnings Report Preview: What To Look For
February 09, 2025
Biotech company Vertex Pharmaceuticals (NASDAQ:VRTX) will be reporting results tomorrow afternoon. Here’s what to look for.
Via
StockStory
We Asked Retail Traders About Eli Lilly’s Biggest Post-Q4 Risk — Most Say It’s The Weight-Loss Drug Wars
February 07, 2025
Lilly’s fiercest competitor in the obesity market is Novo Nordisk, which offers Ozempic and Wegovy. However, rising threats from other players such as Hims & Hers, Amgen, and Viking Therapeutics also...
Via
Stocktwits
Uber To $80? Here Are 10 Top Analyst Forecasts For Thursday
February 06, 2025
Via
Benzinga
What's going on in today's session: S&P500 movers
February 05, 2025
Stay updated with the movements of the S&P500 index one hour before the close of the markets on Wednesday. Discover which stocks are leading as top gainers and losers in today's session.
Via
Chartmill
Stocks Rebound, Google Eyes Worst Drop In A Year, Gold Shatters Fresh Records: What's Driving Markets Wednesday?
February 05, 2025
Wall Street rose on Wednesday, with all major equity indices advancing as investors assessed the latest batch of corporate earnings and drew optimism from positive labor market data.
Via
Benzinga
Stay informed with the top movers within the S&P500 index on Wednesday.
February 05, 2025
Curious about the top performers within the S&P500 index in the middle of the day on Wednesday? Dive into the list of today's session's top gainers and losers for a comprehensive overview.
Via
Chartmill
< Previous
1
2
3
4
5
6
7
8
9
...
46
47
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.